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Introduction
This last decade has witnessed tremendous efforts aimed at developing innovative nanosystems (often formulated as colloids) capable of interacting with cells and tissues [1] [2] [3] [4] [5] . Such systems are especially relevant in the case of cancer pathologies in order to improve the efficacy of cancer treatments while significantly reducing side effects (therapeutic objectives), and also to facilitate early diagnosis therefore limiting cancer-related mortality (diagnosis objectives, e.g., through medical imaging). In the field of cancer diagnosis in particular, detection techniques based on luminescent nanoprobes exhibiting a specific affinity for some diseased cells have particularly raised interest in the view of tumor detection. Many systems of nanoprobes have been considered to-date for such medical imaging abilities, including in particular organic dyes such as green fluorescence protein or DAPI [6] or semiconductor quantum dots [7] [8] [9] , among others. However, toxicity [10, 11] , photobleaching or flickering effects [12, 13] are common limitations to these systems which are thus not particularly suitable for the analysis of biological tissues, especially over extended periods of time. In this context, alternative nanosystems are being investigated, such as lanthanidedoped inorganic nanoparticles which are characterized by narrow emission bandwidths, high photochemical stability and long fluorescence lifetime (up to several milliseconds).
In this view, luminescent colloidal systems based on biomimetic calcium phosphate apatite nanoparticles (similar to bone mineral nanocrystals [14] ) have been synthesized by soft chemistry [15] , where the luminescence was conferred by substituting some calcium ions (a few atomic %) by rare-earth elements such as europium or terbium [16] . The idea to use biomimetic apatite particles as colloidal nanocarriers or nanoprobes is indeed particularly appealing taking into account the high biocompatible character of such apatites that are already present in Human's organisms in bones and teeth. In such nanocrystalline apatite-based systems, the colloidal-like character was linked to the adsorption [17] , on the surface of apatite nanocrystals, of AEP molecules (2-aminoethylphosphate, a phospholipid moiety [18] ) producing electrostatic repulsive effects between neighboring nanoparticles, thus hindering their aggregation. In previous works [15, 19] , the synthesis and main physico-chemical characteristics of such http://dx.doi.org/10.1016/j.powtec.2013.08.008 colloidal nanoparticles (size, morphology, composition and luminescence properties) were investigated, and perspectives in terms of biological evaluations were commented. For example, the possibility to target cancer cells thanks to such apatite-based colloids has been illustrated very recently with the example of breast cancer cells and folic-acid functionalized apatite nanoparticles [16] . Monoclonal antibodies have also been shown to allow cell targeting approaches [20] .
The efficacy of a purification of such apatite-based hybrid suspensions by dialysis process was also followed [19] , this process being used to efficiently eliminate unreacted chemical species. However, macroscopic changes of the suspension state during this dialysis process were noticed (but not investigated in detail), resulting in particular in a more viscous system requiring a subsequent re-suspension treatment.
Taking these considerations into account, we followed in the present contribution various physico-chemical features of (non-luminescent) apatite-based suspensions, either before or after purification by dialysis, so as to better understand their physical state and appreciate their stability behavior.
Based on our results, drying and re-suspension aspects were also examined. Indeed, generally speaking, despite the advantages of drug delivery systems or imaging nanoprobes, several works have reported various potential issues linked to the manipulation of suspensions, including complex manufacturing, potential added toxicity due to the "nano" character of the carriers, and metastability [21] [22] [23] . Stability is indeed one of the critical aspects to take into account for ensuring safety and efficiency of systems used in nanomedicine. The colloidal stability may be affected by various factors such as the nature of the carrier and of the drug, its dose, the dispersion medium, the delivery route (e.g., intravenous, oral, intratumoral, etc.), and of course by production protocols. Stability issues associated with "nanosuspensions" have been widely investigated and can be subcategorized as "physical" and "chemical" stability. Common physical stability issues include in particular sedimentation/creaming effects, agglomeration, uncontrolled crystal growth and change of crystallinity state and can also affect the integrity of the drug or its mode of association with the nanocarrier (e.g., depending on storage and/or transportation conditions). Indeed, the large surface area of nanoparticles creates high total surface energy, which is thermodynamically unfavorable, tending to promote particle agglomeration so as to minimize the surface energy. The most common strategy to tackle this issue is to introduce stabilizers to the formulation. However, the stabilizer selection is known to be very challenging, and in addition to safety and regulation considerations, the selection of stabilizers is based on their ability to provide wetting to surface of the particles and offer a barrier to prevent nanoparticles from agglomeration [24, 25] . Thus, the stability of nanoparticles used in nanomedicine formulations remains a very challenging issue during pharmaceutical developments.
In order to achieve preparations with shelf life of several years, water elimination from aqueous dispersions to obtain a dry solid form appears as the most promising strategy [26] . Freeze-drying technique has already found applications in the preparation of pharmaceutical powders with specific characteristics such as controlled particle size and shape.
The drying process may however be accompanied by an irreversible agglomeration of adjacent nanoparticles, thus potentially hindering further re-dispersion in solution prior to clinical use. The deagglomeration of the clusters could result of different chemical, hydrodynamic and mechanical mechanisms. When the forces causing deformation of the agglomerates exceed the cohesive forces due to interparticle binding, then agglomerates are expected to break-up into smaller fragments [27] . Several studies have pointed out that the kinetics of deagglomeration of nanoparticles-based powder and the morphology and rheology of the resulting suspensions strongly depend on physicochemicals parameters such as pH for example [28] [29] [30] . Another objective of this work was thus to investigate also drying and re-dispersion processes, and to find a way to release the primary nanoparticles without major changes in their physico-chemical characteristics.
Materials and methods

Preparation of biomimetic apatite-based colloids
Apatite-based colloids were obtained by coprecipitation at room temperature of calcium nitrate and ammonium hydrogen phosphate in deionized water, at pH 9.5, in the presence of 2-aminoethylphosphate or "AEP". The precipitates were then allowed to mature in an oven at 100°C for 16 h. The starting AEP/Ca molar ratio was set to 1. For each preparation (25 ml), three aqueous solutions were prepared: solution (A), 6.25 ml, containing 4.87 mmol of calcium nitrate (Ca(NO 3 ) 2 · 4H 2-O), solution (B), 6.25 ml, containing 4.87 mmol of AEP, and solution (C), 12.5 ml, containing 1.62 mmol of ammonium hydrogenphosphate. Solution (A) was mixed with solution (B) under constant stirring. The acidic pH of the resulting solution as well as that of solution (C) were re-adjusted to 9.5 by addition of ammonia.
Purification by dialysis process
In this study, a tubular cellulose membrane (length: 15 cm, diameter: 3 cm, cutoff: 6000-8000 Da) was used as dialysis membrane, containing 25 ml of the suspension to dialyze. The membrane was held vertically and introduced in 800 ml of dialysis medium (deionized water). The washing medium was continually homogenized by mechanical stirring, and regularly exchanged by a fresh one (changes after 4, 8, 22 and 26 h of dialysis) so as to regenerate the concentration gradient and accelerate the purification process. The dialysis process was carried out at room temperature (25°C).
When mentioned in the text, reagent grade sodium hexametaphosphate (denoted here "HMP") was added on the colloids after purification by dialysis in view of optimal particle dispersion. Typically, 1 ml of HMP aqueous solution at 0.08 M were added to 12.5 ml of the colloidal suspension.
Freeze-drying and redispersion
The suspensions were dried by freeze-drying. When mentioned in the text, glucose was added to the medium (150 mg of glucose added to 13.5 ml suspension, composed of 12.5 ml of colloid and 1 ml of HMP solution at 0.08 M) prior to the freeze-drying step. This biocompatible molecule was selected in view of forming, upon freeze-drying, a water-soluble solid matrix hindering the agglomeration of adjacent nanoparticles (as is generally noticed during water elimination from aqueous suspensions). The dry composite apatite/glucose agglomerates thus formed upon drying were then allowed to be redispersed in water, under moderate magnetic stirring (about 300 rpm).
Physico-chemical characterizations
The crystallographic structure of the powders obtained after freezedrying the suspensions was investigated by way of X-ray diffraction (XRD) using a CPS 120 INEL diffractometer with the Kα1 Cobalt radiation (1.78892 Å). For complementary analyses, Fourier transform infrared (FTIR) spectroscopy analyses were performed on a Nicolet 5700 spectrometer, in the wavenumber range 400-4000 cm −1 (resolution 4 cm
−1
). The calcium content of the nanoparticles was determined by induced coupled plasma atomic emission spectroscopy, ICP-AES (relative uncertainty 3%). The amount of mineral phosphate (from apatite) was measured by colorimetry at λ = 460 nm, using the yellow phosphovanado-molybdenum complex [31] (relative uncertainty 0.5%). The AEP content associated to the colloidal nanoparticles after purification by dialysis (thus after removal of all nitrate counter-ions) was drawn from nitrogen microanalysis (relative uncertainty 0.4%).
The particle size distributions of the suspensions were characterized without any dilution by dynamic light scattering (DLS) using a Zetasizer Nano ZS (Malvern Instruments Ltd), with a backscattered light (λ = 630 nm, θ = 173°). Punctual zeta potential measurements based on electrophoresis of the particles were carried out on the same apparatus using an adapted U-shaped measurement cell. For zeta potential measurements, no dilution was performed and the suspensions were tested as-prepared (synthesis pH of 9.5) without modification of medium.
Measurements of the rheological properties of the suspensions were performed with an AR rheometer (TA Instruments) at 25°C. The suspensions were analyzed by simple shear measurements using a parallel geometry (gap 1 mm) with serrated plates (diameter 60 mm).
Statistical relevance for the particle size and rheology measurements was tested on the basis of quadruplicate experiments.
Results and discussion
Structural and compositional analyses
The suspensions prepared in this contribution by apatite precipitation in the presence of 2-aminoethylphosphate (AEP) and purified by dialysis were first characterized by XRD and FTIR analyses. Figs. 1 and 2, respectively, report an XRD pattern and an FTIR spectrum that are typical of such colloidal nanoparticles, and these data confirmed the apatitic nature of the particles (main XRD diffraction lines corresponding to hydroxyapatite, space group P6 3 /m (hexagonal), have been added on Fig. 1 ).
Chemical analyses, however, indicated that the Ca/P mole ratio of the apatite phase was close to 1.42 and thus significantly lower than the value (1.67) found for hydroxyapatite. This finding points out the nonstoichiometry of such an apatite phase (closer to bone-like apatite). The AEP/apatite ratio characteristic of the sample was equal to 0.80. On the basis of nitrogen titration via elemental analyses, this amount of AEP was found to correspond to 11 wt.% in the hybrid apatite/AEP system. The presence of AEP molecules associated with the apatite phase was confirmed (Fig. 2) by the presence of an absorption band at 754 cm −1 , which is characteristic of the P-O(C) vibration mode in systems such as Ca(AEP) 2 where a close interaction between AEP molecules (exhibiting one global negative charge at the synthesis pH) and Ca 2+ ions is involved, as was discussed in previous works [15, 28] .
Surface charge analyses and stability
Zeta potential values obtained with these suspensions were systematically found to be positive (ζ ≈ +12 mV at the synthesis pH of 9.5) despite some variability, that is in good agreement with the presence of adsorbed AEP molecules, exposing their ammonium -NH 3 + endgroups toward the solution (while the phosphate end of the AEP molecule interacts with the Ca 2+ ions [32] ). It may, however, be noted that this zeta potential value remains quite low (in absolute value), which thus does not enable us to describe such suspensions as highly stable, which is generally considered for absolute values above 30 mV.
Particle size characterizations
Optical observations (macroscopic), however, indicated that the assynthesized colloids did not undergo sedimentation. DLS measurements on such as-prepared suspensions confirmed the nanometer-scale dimensions of the particles, with a unimodal size distribution centered around 30 nm. In order to inspect further the stability of these colloids, additional DLS measurements were carried out 1, 4, 7 and 15 days after synthesis (Fig. 3) . In all cases, the mean hydrodynamic diameter was found to remain close to 30-35 nm. Interestingly, although a slight increase in mean particle size towards 35 nm was noticed here, no significant change could be seen over a period of 2 weeks after synthesis.
Rheological behavior of the suspensions
Rheological characterization showed that the suspensions had a rheofluidifying behavior, witnessed by a (nearly exponential) decrease of the suspension viscosity upon increase of the shear rate: in the range 0.1 to 0.001 Pa.s for shear rates varying from 0 and 300 s . However, the viscosity of the suspensions was found to follow some evolutional trend, increasing progressively upon ageing, which was followed over a period of 2 weeks. Moreover, a progressive increase of shear stress (see Fig. 4 ) was evidenced, tending towards a threshold value close to 0.1 Pa (starting value at zero shear rate) after few days of ageing. These results thus suggest that, although no sedimentation occurs, a progressive structuration of the suspension happens upon Fig. 1 . XRD pattern for biomimetic apatite-based colloids stabilized by AEP molecules (prepared at 100°C, and pH 9.5), after dialysis purification. Fig. 2 . FTIR spectrum for biomimetic apatite-based colloids stabilized by AEP molecules (prepared at 100°C, and pH 9.5), after dialysis purification. Fig. 3 . DLS measurements versus time, for biomimetic apatite-based colloids stabilized by AEP molecules (prepared at 100°C, and pH 9.5).
ageing, which underlines some limitations in the time-dependent stability of these suspensions.
Purification of the suspensions by dialysis
In a second step, the colloids stability was examined during the purification process of dialysis and analyses of the suspension were done for increasing durations of dialysis between 0 and 26 h of process. The follow-up of the particle size distributions versus time (Fig. 5 ) then pointed out a noticeable alteration in terms of particle size, marked by a global increase of the mean diameter of the particles and the appearance upon dialysis of new populations of aggregates around 100 nm and then 300-600 nm ( Table 1) . As it can be shown, the particle size distribution of the suspension quite remains the same after 4 h of dialysis. But after 8 h, aggregates of very different sizes have appeared and a large peak (σ ≈ 106 nm) centered on medium aggregates sizes (d2 peak ≈ 153 nm) can be observed. Then as the dialysis process goes on, the particle size distributions highlight the existence of three populations: primary particles, and two populations of aggregates.
This size effect was accompanied by a progressive increase of the viscosity of the suspension during the dialysis process as shown in Fig. 6 . During this type of size measurements, the auto-correlation function of each analysis also gives interesting information about the suspension and the quality of the results. Then the corresponding correlograms were verified too and they indicated the likely presence of larger particles or aggregates (larger than the upper limit of the apparatus which is over 6 μm), and of a significant polydispersity of the particles at this stage.
Although the rheofluidifying behavior of the suspension was conserved at all times during the dialysis process (Fig. 6) , the increase in viscosity may be related to the above-mentioned increase of particle size, witnessing the evolution of the suspension structuration upon dialysis. In addition to possible dissolution-reprecipitation phenomena during the dialysis process, these effects may probably be linked to the desorption of some AEP molecules out of the surface of the apatite nanocrystals, therefore lowering the strength of electrostatic repulsive forces at the origin of the limitation of agglomeration. This is indeed supported by the fact that the relative intensity of the FTIR band at 754 cm −1 related to adsorbed AEP tends to decrease progressively as the dialysis process progresses (not shown here for the sake of brevity).
Very interestingly, we showed, however, that the addition of a dispersing agent involving multiple ionic end-groups, such as sodium hexametaphosphate, led to the recovery of a size closed to the mean particle size of the colloidal nanoparticles (as measured before dialysis), i.e., close to 40 nm (Fig. 7) . After HMP addition, the observable refluidification effect was (as expected) accompanied by a quantitative decrease of the suspension viscosity, reaching the initial value obtained before dialysis (Fig. 6 ). The addition of HMP in the medium, which exhibits 6 negatively charged phosphate "heads," is indeed likely to interact with the surface of the apatite nanoparticles covered with AEP molecules and presenting some peripheral positively charged amino groups. Such an interaction could then probably explain the refluidification effect observed, by an increased separation of adjacent nanoparticles, thus indicative of a re-individualization of the nanoparticles (destruction of the above-mentioned structuration of the suspension). Zeta potential measurements performed on such HMPtreated colloids indeed pointed out a change in sign of the nanoparticles in the presence of HMP molecules, typically reaching −16 mV [17] . Fig. 8 shows the typical morphology of nanoparticles obtained, after synthesis and HMP treatment, as observed by Transmission Electron Microscopy (TEM).
Taking into account the final objective of use of such colloids, the stability of such purified and HMP-redispersed suspensions was also checked in a preliminary way by subjecting them to the presence of (1) albumin (the main protein present in human plasma) at a concentration similar to that found in vivo (i.e. 43 g/l), (2) a solution of simulated body fluid (SBF) and (3) a mixture of the two. The colloidal stability was found to be retained at least for one week after such treatments without any detectable sign of agglomeration or sedimentation thus suggesting a possible use in contact with plasma. Table 1 Characteristic diameters of the particle size distributions of the suspension during the dialysis process. d ipeak (nm) is the mode of the peak i, σ (nm) the standard deviation of d ipeak and Propi (%) is the proportion of intensity of the mode of the peak i comparing to the other modes (Prop1 + Prop2 + Prop3 =100%). 
Drying and redispersion of the particles
The above findings indicate that some alterations of the suspensions physico-chemical properties, especially in terms of viscosity and/or mean particle size, could be noticed and followed upon ageing and/or during the dialysis purification process itself. It was thus interesting at this point to attempt to dry such suspensions (in view of significantly facilitating their storage over extended periods of time) while retaining an ability to be re-suspended in aqueous medium without significant change in particle size. First drying experiments carried out either in a drying oven or by direct freeze-drying were unsuccessful as they led to noticeably agglomerated particles in a rather irreversible way, which was evidenced by a sedimentation of part of the particles, even upon sonication. These findings may probably be linked to the high surface energy of apatite nanocrystals which are prone to interact strongly with each other, upon elimination of water, in view of minimizing the total surface energy of the system [33] . In this context, preliminary experiments were then run by freeze-drying the suspensions after addition of glucose in the medium (150 mg in 13.5 ml suspension, composed of 12 ml of colloid and 1 ml of HMP solution at 0.08 M). The original underlying idea in the use of glucose here is in fact linked to its water solubility: glucose (if added in sufficient quantity) is indeed expected to form a solid matrix "embedding" the apatite nanoparticles, thus hindering their agglomeration upon drying; while re-immersion in water at the time of use will again liberate the nanoparticles by solubilization of the glucose "embedding" matrix. In this case, re-suspension was found to be successful as no sedimentation occurred and DLS experiments revealed that no major change in particle size was detected as compared to the initial suspension (mean hydrodynamic diameter close to 40 nm) (Fig. 7) . Therefore, the colloidal behavior of the nanoparticles after redispersion was not affected. These results suggest that the addition of glucose into the system indeed formed the expected (water-soluble) matrix around the nanoparticles during the freezedrying process, thus preventing their interaction/aggregation. After reimmersion, the solubilization of glucose then permitted to retrieve individual dispersed nanoparticles. These findings are thus promising in view of the storage over long periods of time of such colloids (under their dry state) for the setup of innovative injectable colloids for medical imaging or intracellular therapeutic applications.
For gaining additional insight on the behavior of such dried suspensions during re-immersion processes, redispersion experiments were done with varying volumes (thus leading to different conditions of particle concentrations). The dilution factor, f, was varied between 0.5 and 4 (f being the ratio between the volume of the suspension after redispersion and the volume of the suspension before freeze-drying). The evolution of the particle size distributions was characterized by DLS during the redispersion process and kinetics of redispersion can be represented by the evolution of the particle mean diameter versus time as in Fig. 9 . It can be concluded that whatever the concentration, a size close to the primary particles size is reached after about 30 min of agitation. The decrease in size is first very fast (about 5-10 min), then it still decreasing more slowly and there is a stabilization until about 30 min. Furthermore, the higher the dilution factor, the faster the redispersion. Fig. 6 . Comparison of the rheograms for a nanocrytalline apatite suspension after synthesis (non dialyzed), then at the end of the dialysis process and finally after the HMP addition. Fig. 7 . Comparison of the particle size distribution on the suspension after synthesis, after dialysis and the HMP addition and at the end of the redispersion process. These findings thus indicate that it is possible to store such AEPstabilized nanocrystalline apatite suspensions in a dry state, e.g., by addition of water-soluble glucose prior to the drying process, while preserving their ability to be redispersed in aqueous medium (and in varying concentrations) at the time of use. This statement is important in view of the possible use of such nanosuspensions in nanomedicine applications.
Concluding remarks
In this work, various physico-chemical features of colloidal-like suspensions formed of apatite nanoparticles functionalized by 2-aminoethylphosphate were examined. In particular, an evolution of the suspensions viscosity and/or mean particle size was evidenced upon ageing or during the purification process of dialysis, leading to their progressive structuration. The addition of a dispersing agent, in this case sodium hexametaphosphate, however, enabled us to efficiently re-suspend the nanoparticles after dialysis, and the addition of glucose (a watersoluble matrix-forming biocompatible molecule) allowed us to freezedry the suspensions while retaining their ability to be re-suspended, thanks to the formation of a glucose matrix around the particles during the drying process, thus hindering their agglomeration.
This contribution thus sheds some more light on the physicochemistry and colloidal (meta)stability of suspensions prepared from biomimetic apatite/AEP hybrid compounds, thus unveiling potential limitations and interests of such biocompatible compounds intended for medical imaging or intracellular therapeutic applications.
Nomenclature
Latin letters d ipeak mode of the peak i of the particle size distribution (nm) f dilution factor (−) Propi proportion of intensity of the mode of the peak i (%)
Greek letters λ wave length (nm) θ scattering angle (°) ζ zêta potential (mV) σ standard deviation (nm) Acronyms AEP 2-aminoethylphosphate DLS dynamic light scattering FTIR Fourier transform distribution HMP hexametaphosphate ICP-AES induced coupled plasma atomic emission spectroscopy TEM transmission electron microscopy XRD X-ray diffraction
